eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2011
vol. 62
 
Share:
Share:
abstract:

Serous neoplasms of the pancreas constitute a continuous spectrum of morphological patterns rather than distinct clinico-pathological variants. A study of 40 cases

Jacek Pająk
,
Łukasz Liszka
,
Sławomir Mrowiec
,
Ewa Zielińska-Pająk
,
Dariusz Gołka
,
Paweł Lampe

POL J PATHOL 2011; 3: 206-217
Online publish date: 2012/01/10
View full text Get citation
 
Serous neoplasms (SN) of the pancreas account for 1-2% of all pancreatic tumours. Six morphological variants of SN were previously recognized: serous microcystic (cyst)adenoma, serous macrocystic (cyst)adenoma, von Hippel-Lindau-associated serous cystic neoplasm, solid serous adenoma/neoplasm, mixed serous-neuroendocrine neoplasm and serous cystadenocarcinoma. It was recently postulated that SN shows a continuous spectrum of morphological patterns rather than distinct clinico-pathological subtypes. To address this issue, we performed a detailed review of 40 SN cases diagnosed at our institution between 1989 and 2011. We found 11 cases of serous microcystic (cyst)adenoma, 5 cases of serous macrocystic (cyst)adenoma, and a single case of von Hippel-Lindau-associated serous cystic neoplasm. Apart from that, we found 20 cases of SN which showed features of both microcystic and macrocystic (cyst)adenomas, 2 cases of small ‘incipient’ SN and a single case of a mixed microcystic and solid adenoma. In conclusion, we showed that ‘borderline’ lesions among SNs truly exist and are not rare. The reason for such a wide diversity of morphological patterns of SN remains unknown.
keywords:

serous neoplasms of the pancreas, pancreatic neoplasms, pancreas

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.